Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
Greg.Corboy1 (talk | contribs) |
Greg.Corboy1 (talk | contribs) |
||
| Line 1,907: | Line 1,907: | ||
| | | | ||
|- | |- | ||
| Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease|| | | Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|GC | |GC | ||
| | | | ||
| | |Anna Shestakova FQR removed March 2022 after no contact/input for >1y | ||
|- | |- | ||
|''''' Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| | |''''' Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| | ||
| Line 1,989: | Line 1,987: | ||
| ||GC | | ||GC | ||
| | | | ||
| | |emailed 28/3/2022 to get update | ||
|- | |- | ||
| Langerhans Cell Sarcoma||Disease||Malaika Perchard, Greg Corboy | | Langerhans Cell Sarcoma||Disease||Malaika Perchard, Greg Corboy | ||
| Line 1,997: | Line 1,995: | ||
| ||GC | | ||GC | ||
| | | | ||
| | |emailed 28/3/2022 to get update | ||
|- | |- | ||
|Indeterminate Dendritic Cell Tumour||Disease|| | |Indeterminate Dendritic Cell Tumour||Disease|| | ||
| Line 2,053: | Line 2,051: | ||
| ||GC | | ||GC | ||
| | | | ||
| | |emailed 28/3/2022 to get update | ||
|- | |- | ||
| || || | | || || | ||